John­son & John­son is an­tic­i­pat­ing as much as $750 mil­lion in costs to re­struc­ture its phar­ma­ceu­ti­cal sup­ply chain and ex­it fac­to­ries, moves that are com­ing …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.